MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview, including an update on anticipated clinical development plans and timelines for the Ostarine™ (GTx-024) and Capesaris™ (GTx-758) programs, on January 13th at the 29th Annual JP Morgan Healthcare Conference in San Francisco. The GTx presentation will begin at 1 p.m. Pacific Time. A simultaneous webcast of the presentation will be accessible from the GTx website at www.gtxinc.com. An archived replay of the presentation will be available on the company website until January 27.
